The American Journal of Managed Care^® is issuing a call for papers on obesity treatment. These papers, in addition to the journal’s regular content, will be published throughout upcoming issues of the journal.

Obesity is a serious, progressive, chronic disease associated with a spectrum of complications and poor outcomes. Until recently, FDA-approved medications for the long-term treatment of obesity in the general adult population had not demonstrated the ability to achieve guideline-recommended levels of body weight loss. The recent introduction of highly effective anti-obesity medications has provoked a sea change in the treatment of obesity, with new guidelines now recommending use of these novel therapies for the long-term treatment of obesity. However, these clinical advances also carry questions of how to ensure patients can access and pay for these therapies.

Click here to view the Call for Papers.